CMA Invites Views on Danone's Anticipated Acquisition of UK Meal-Replacement Brand Huel
The Competition and Markets Authority (CMA) has opened a public consultation on Danone's anticipated acquisition of Huel Ltd, the UK-based meal-replacement producer. The regulator invited comments on Wednesday as part of its standard merger review process, marking the formal commencement of scrutiny into a deal that brings together one of the world's largest food and beverage multinationals with a fast-growing British direct-to-consumer nutrition brand. Huel has built a significant consumer following in the UK and internationally across its range of nutritionally complete powder, bars, and ready-to-drink products. Danone, the Paris-headquartered group behind brands including Evian, Activia, and Alpro, would gain a foothold in the rapidly expanding functional nutrition and meal-replacement segment through the transaction. The CMA's decision to seek third-party views is a routine step in Phase 1 merger review in the UK. The regulator will assess whether the combination could result in a substantial lessening of competition in any relevant market — most likely the UK meal-replacement and functional nutrition space. No deal value has been publicly disclosed. No legal advisers have been named in available sources. The transaction sits within a broader pattern of large food multinationals acquiring premium wellness and nutrition brands as consumer preferences shift toward convenience-led health products. For Danone, an acquisition of Huel would represent a strategic push into a segment with younger demographics and strong subscription-based revenue, areas where legacy food groups have sought inorganic growth.
Why this matters
A CMA Phase 1 merger review of this type creates immediate demand for competition law advice on both sides — counsel must prepare substantive submissions addressing market definition, competitive overlap, and counterfactual analysis. The key legal question is whether Danone's existing presence in adjacent nutritional categories (plant-based drinks, dairy alternatives) creates a material overlap with Huel's meal-replacement products sufficient to trigger a Phase 2 reference. If the CMA proceeds to an in-depth Phase 2 investigation, deal timetables extend significantly and remedies (structural or behavioural) may be required. The 'why now' driver is consolidation pressure in the consumer nutrition space as food majors seek growth in high-margin, direct-to-consumer wellness categories. No advisers are named in the sources, but transactions of this profile typically activate competition, corporate, and regulatory practice groups at UK and EU law firms.
On the Ground
A trainee on this matter would help draft the CMA merger notification submission, preparing a CP (conditions precedent) checklist tracking regulatory clearance milestones and coordinating responses to any third-party information requests issued by the regulator. They would also assist with due diligence report indexing across Huel's product portfolio and UK market share data to support the competition analysis.
Interview prep
Soundbite
Danone-Huel puts UK meal-replacement market definition squarely before the CMA — Phase 2 risk depends on how narrowly the regulator draws the category.
Question you might get
“How would you advise Danone on the risk of a CMA Phase 2 referral, and what remedies might the regulator consider if it found a substantial lessening of competition in the UK meal-replacement market?”
Full answer
The CMA has opened a public consultation on Danone's planned acquisition of Huel, the British meal-replacement brand. This matters because it activates UK merger control at a time when the CMA is scrutinising consumer goods consolidation carefully, and a Phase 2 referral would substantially delay closing and increase deal costs for both parties. The broader trend is that large food multinationals are pursuing inorganic growth in premium wellness and direct-to-consumer nutrition brands, where organic growth is harder to achieve. Competition lawyers will be watching closely how the CMA defines the relevant market — a narrow 'meal replacement' frame creates greater overlap risk than a broader 'food and beverage' definition.
My notes
saved